Differential G protein activation by the long and short isoforms of the dopamine D2 receptor

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Background and Purpose: The dopamine D2 receptor is expressed as a short (D2S) and a long (D2L) isoform with 29 additional amino acids in the third intracellular loop. The D2S isoform shows higher presynaptic expression than the D2L isoform, and decreased D2S expression has recently been linked to an increased risk for schizophrenia. Here, we present the first investigation, at receptor isoform level, of kinetic differences in the G protein activation profiles of the D2S, compared with the D2L isoform. Experimental Approach: We employed a NanoBRET-based approach to G protein dissociation to interrogate the time-resolved coupling profile of 3×HA-tagged D2L and D2S to Gαi/o/z proteins in vitro. Key Results: Using dopamine as a D2 receptor agonist, we observed a more pronounced activation of Gαo and Gαz than Gαi proteins by D2L compared with D2S. This differentiation was not observed for D2S, which activated Gαo and Gαz with lower efficacy than D2L. These signalling differences were preserved on second messenger level and were not due to differences in receptor expression. Expanding to a set of seven full and partial D2 receptor agonists showed these effects were not restricted to dopamine but rather a mutual, receptor-associated property. Contrasting this trend, we found that D2S activated G proteins faster than D2L upon full receptor activation. Conclusion and Implications: The findings highlight that both D2L and D2S are mechanistically able to activate all non-visual Gαi/o proteins. Thereby, they add to previous reports about isoform-specificity to certain Gαi/o proteins observed in specific cell types.

OriginalsprogEngelsk
TidsskriftBritish Journal of Pharmacology
ISSN0007-1188
DOI
StatusAccepteret/In press - 2024

Bibliografisk note

Funding Information:
This work was supported by the Lundbeck Foundation (grant R278\u20102018\u2010180) and Carlsberg Foundation (grant CF20\u20100248). D.E.G. acknowledges financial support from the Novo Nordisk Foundation (NNF18OC0031226) and the Lundbeck Foundation (R383\u20102022\u2010306 and R313\u20102019\u2010526). We further acknowledge the European Research Network on Signal Transduction for the fruitful input to this manuscript (ERNEST, EU COST\u2010action CA18133), and for financial support for technical training (D.R.\u2010L.). Parts of illustrations were drawn based on freely available pictures from Servier Medical Art ( https://smart.servier.com/ ), which is licensed under a Creative Commons Attribution 3.0 Unported License ( https://creativecommons.org/licenses/by/3.0/ ). We are grateful to Kasper Harps\u00F8e for the critical input to the manuscript.

Publisher Copyright:
© 2024 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

ID: 392449877